<b>Conclusions:</b> These findings establish <i>CYP2R1</i> as a novel metabolic and immunogenomic biomarker in HCC, linking hepatic metabolism, genomic maintenance, and tumor immune modulation. This evidence concerns the gene CYP2R1 and hepatocellular carcinoma.